Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. Issue 3 (March 2017)

• Record Type: Journal Article
• Authors: Fowler, Mary G.; Qin, Min; Fiscus, Susan A.; Currier, Judith S.; Flynn, Patricia M.; Chipato, Tsungai; McIntyre, James; Gnanashanmugam, Devasena; Siberry, George K.; Coletti, Anne S.; Taha, Taha E.; Klingman, Karin L.; Martinson, Francis E.; Owor, Maxensia; Violari, Avy; Moodley, Dhayendre; Theron, Gerhard B.; Bhosale, Ramesh; Bobat, Raziya; Chi, Benjamin H.; Strehlau, Renate; Mlay, Pendo; Loftis, Amy J.; Browning, Renee; Fenton, Terence; Purdue, Lynette; Basar, Michael; Shapiro, David E.; Mofenson, Lynne M.
• Is Part Of: Obstetrical & gynecological survey. Volume 72:Issue 3(2017)
• Publication Date: 2017-03
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/OGX.0000000000000427
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from N Engl J Med 2016;375:1726–1737) Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transmission of HIV but has shown more adverse effects compared with regimens containing fewer antiretroviral agents.